SK Chemicals Co., Ltd.: all 69 studies

Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.

• SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 YearsRecruitingNCT07415252Phase 3
• An Open-label Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of SKP-0141 for the Treatment and Prophylaxis in Severe Hemophilia a PatientsNot yet recruitingNCT06738901Phase 3
• Immunogenicity and Safety of Quadrivalent Influenza Vaccine (NBP607-QIV) in Adults and Elderly SubjectsCompletedNCT02467842Phase 3Results posted
• Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and AmlodipineCompletedNCT00626743Phase 1Results posted
• A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults.Active, not recruitingNCT07280858Phase 1/2
• A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy AdultsCompletedNCT06680128Phase 1/2
• Efficacy and Safety of SKCPT in Patients With Knee Osteoarthritis: Phase III Clinical TrialCompletedNCT05930080Phase 3
• A Study to Compare the Effects of Improving the Carotid Artery Intima Media Thickness and Changing Lipid Levels by Cilostazol/Ginkgo Leaf Extract and Aspirin in Diabetic Peripheral Angiopathy.CompletedNCT05906199Phase 4
• A Blood Collection Study to Assess the Immunogenicity of Nationally Authorized Homologous COVID-19 Booster Vaccines Among Adult Vaccinees.WithdrawnNCT05710289
• A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in ABO-Incompatible Liver TransplantationTerminatedNCT05666453Phase 2
• A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP)CompletedNCT05566990Phase 3
• Immunogenicity and Safety Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine(GBP510) Adjuvanted with AS03 in Adults Aged 18 Years and OlderCompletedNCT05501522Phase 3
• A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult VolunteersCompletedNCT05453786Phase 1
• A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic StrokeCompletedNCT05445895Phase 4
• Clinical Trial for GNX80 in Intermittent ClaudicationStatus unknownNCT05400395Phase 4
• A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult VolunteersCompletedNCT05236998Phase 1
• Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19)CompletedNCT05007951Phase 3
• A Study to Evaluate the add-on Efficacy and Safety of Opicapone 50 mg or an Extra Dose of L-DOPA 100 mg for the Treatment of Wearing-off in Patients With PDCompletedNCT04821687Phase 4
• Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19)CompletedNCT04760743Phase 1
• Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19)Status unknownNCT04750343Phase 1/2
• Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19)CompletedNCT04742738Phase 1/2
• Immunogenicity and Safety Study of NBP615 in Healthy FemaleCompletedNCT04453241Phase 1/2
• The Evaluation of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of QDX in Healthy Korean Male SubjectsCompletedNCT04401137Phase 1
• Safety, Tolerability and Immunogenicity of an Trivalent Inactivated Cell-Culture Influenza Vaccine in Healthy AdultsCompletedNCT03893669Phase 1
• Safety, Tolerability and Immunogenicity of NBP607QIV in Healthy Adult VolunteersCompletedNCT03826719Phase 1/2
• Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 MonthsCompletedNCT03704740Phase 3
• Clinical Trial to Evaluate Efficacy and Safety of SID142 in Patients With Chronic Artery Occlusive DiseaseCompletedNCT03318276Phase 3
• A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)CompletedNCT03164915Phase 3
• Safety Study of NBP608 in Healthy Adult VolunteersCompletedNCT03121638Phase 1
• Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and OverCompletedNCT03120364Phase 3
• Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and OverCompletedNCT03116594Phase 2/3
• The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of AgeCompletedNCT03114982Phase 2
• Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of AgeCompletedNCT03114943Phase 3
• Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 MonthsCompletedNCT03020628Phase 3
• Immunogenicity and Safety Study of NBP606 in Healthy ToddlersCompletedNCT02927444Phase 3
• Safety/Tolerability and Pharmacokinetic Study of SID142CompletedNCT02625714Phase 1
• Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Healthy Children and AdolescentsCompletedNCT02621177Phase 3
• Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and AdolescentsCompletedNCT02621164Phase 3
• Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OABCompletedNCT02485067Phase 3
• Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mgCompletedNCT02485041Phase 1
• Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mgCompletedNCT02485028Phase 1
• Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Adult and Elderly SubjectsCompletedNCT02344134Phase 3
• Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of SKI2670CompletedNCT02202408Phase 1
• Immunogenicity and Safety Study of NBP606 in Healthy InfantsCompletedNCT02201030Phase 3
• Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With ConstipationCompletedNCT02082457Phase 2
• Study to Assess the Efficacy and Safety of SKI3246 in Subjects With Non-Constipation Irritable Bowel SyndromeCompletedNCT02079675Phase 2
• Study Immunogenicity and Safety of 13-valent Pneumococcal Conjugate VaccineCompletedNCT02079207Phase 3
• Study Phase III Study to Assess the Efficacy and Safety of SOTB07 in Asthma PatientsTerminatedNCT01907763Phase 3
• Study to Assess the Efficacy and Safety of SK-MS10 in Subjects With Acute and Chronic GastritisCompletedNCT01578811Phase 2
• Clinical Study to Evaluate the Pharmacokinetic Characteristics Between TMX-67 and Feburic® in Healthy VolunteersCompletedNCT01563432Phase 1
• A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation RecipientsCompletedNCT01513850Phase 3
• Efficacy and Safety Study of TRK-820 to Treat Conventional-treatment-resistant Pruritus in Patients Receiving HemodialysisCompletedNCT01513161Phase 3
• Assessment of Protective Effect of JOINS on Cartilage in Knee OsteoarthritisCompletedNCT01293955Phase 4
• A Confirmatory Trial of SK-PC-B70M in Mild to Moderate Alzheimer's DiseaseCompletedNCT01249196Phase 3
• Safety Study of TRK-820 for Patient With HemodialysisCompletedNCT01248650Phase 1
• Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent AsthmaCompletedNCT00936624Phase 2
• Study to Evaluate SID 530 Compared to TaxotereCompletedNCT00931008Phase 3
• Phase1 Syudy to Evaluate the Safety and PK/PD of Human Antithrombin IIICompletedNCT00846274Phase 1
• A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of MigraineCompletedNCT00821483Phase 3
• Phase III Trial of Febuxostat in Korea Gout PatientsCompletedNCT00821392Phase 3
• Study to Assess the Efficacy and Safety of SK3530 on Erectile Dysfunction in Patients With Diabetes MellitusCompletedNCT00705861Phase 3
• Study to Assess the Effect of Pharmacokinetics/Pharmacodynamics (PK/PD) Interaction After co-Administration of Cilostazol With Ginkgo Biloba or PlaceboCompletedNCT00689858Phase 1
• Phase III Study to Assess the Efficacy and Safety of SK3530 in Patients With Erectile Dysfunction and HypertensionCompletedNCT00644007Phase 3
• Phase I Study to Investigate the Drug Interaction After Oral Administration of Tamsulosin and SK3530CompletedNCT00489606Phase 1
• Phase I Study to Investigate the Alcohol Interaction of SK3530CompletedNCT00489450Phase 1
• Phase 1 Study of SK3530 to Investigate of the Effect of FoodCompletedNCT00443625Phase 1
• A Trial of SK-PC-B70M in Mild to Moderate Alzheimer's DiseaseCompletedNCT00443417Phase 2
• Phase II Trial of SK3530 in Erectile DysfunctionTerminatedNCT00351065Phase 2
• Efficacy and Safety Study of S-Amlodipine Gentisate Compared to Amlodipine Besylate to Treat Mild-to-Moderate HypertensionCompletedNCT00289406Phase 3

← SK Chemicals Co., Ltd. overview and focus areas